Insulin-like growth factor (IGF) binding protein 3 (IGFBP3) is a major carrier of IGF1 and IGF2 in circulation and IGFBP3 levels are reduced in breast cancer patients, giving rise to higher free IGF1 levels and poor prognosis (25,26). This evidence concerns the gene IGFBP3 and breast carcinoma.